Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment

BACKGROUND/AIMS: Adalimumab dose escalation is one of the most important options in refractory Crohn's disease patients with loss of response to adalimumab. The goal of this study was to evaluate the effectiveness of adalimumab dose escalation in Crohn's disease patients with loss of respo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case Rep Gastroenterol
Hauptverfasser: Suzuki, Taketo, Mizoshita, Tsutomu, Sugiyama, Tomoya, Hirata, Yoshikazu, Kimura, Yoshihide, Suzuki, Yuka, Yamada, Tomonori, Tsukamoto, Hironobu, Mizushima, Takashi, Sugimura, Naomi, Katano, Takahito, Tanida, Satoshi, Kataoka, Hiromi, Sasaki, Makoto
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2019
Schlagworte:
Case Series
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547276/
https://ncbi.nlm.nih.gov/pubmed/31182942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496453
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge